Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - SELLING, GENERAL & ADMINISTRATIVE
Selling, General & Administrative DNLI - Denali Therapeutics Inc.
103 M
LAST VALUE
14.34%
2 YEAR CAGR
26.15%
5 YEAR CAGR
0.00%
10 YEAR CAGR